Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated
Kristine Mørk Kindberg1,2, Kaspar Broch3,4, Geir Øystein Andersen5
1Department of Cardiology, Center for Clinical Heart Research, Oslo University Hospital Ullevaal, Oslo, Norway.
JACC. Advances
|September 9, 2024
Summary
Tocilizumab treatment reduced neutrophil extracellular traps (NETs) in ST-segment elevation myocardial infarction (STEMI) patients. This reduction in NETs was associated with improved myocardial salvage, suggesting a potential therapeutic mechanism.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Interleukin-6 receptor inhibition with tocilizumab demonstrates improved myocardial salvage in ST-segment elevation myocardial infarction (STEMI) patients.
- Reduced levels of neutrophil extracellular traps (NETs) may contribute to the therapeutic effects of tocilizumab.
Purpose of the Study:
- To evaluate tocilizumab's effect on NETs in STEMI patients.
- To investigate the association between NETs and myocardial injury.
Main Methods:
- The ASSAIL-MI substudy randomized 199 STEMI patients to tocilizumab or placebo.
- NET markers (dsDNA, myeloperoxidase-DNA, H3Cit) were measured at multiple time points.
- Associations between NET markers and myocardial salvage index (MSI) were analyzed.
Main Results:
- Tocilizumab significantly reduced all NET markers compared to placebo at 3-7 days post-treatment (P < 0.04).
- NET-related pathways were downregulated in the tocilizumab group.
- Reduced NET levels partially mediated tocilizumab's beneficial effect on MSI.
Conclusions:
- Tocilizumab effectively reduces NETs in STEMI patients.
- NET reduction by tocilizumab is associated with myocardial injury.
- The therapeutic effect of tocilizumab on myocardial salvage index may be mediated by reduced NETs.
Related Concept Videos
Myocarditis I: Introduction
102
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
102
Acute Coronary Syndrome III: Diagnostic Studies
55
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55
Acute Coronary Syndrome I: Introduction
185
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
185
Myocarditis II: Clinical Features and Diagnostic Tests
65
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
65


